People On The Move: Appointments At Dr Reddy's, Mayoly, NèreS

People On The Move: Appointments At Dr Reddy's, Mayoly, NèreS

 
• By 

A round-up of the latest appointments in Europe's consumer health industry: Dr Reddy's hires UK head; Mayoly names CEE lead; NèreS adds director.

US FDA’s Petition Procedures No Place For OTC Acetaminophen Pediatric Dosing Enforcement

US FDA’s Petition Procedures No Place For OTC Acetaminophen Pediatric Dosing Enforcement

 

Requests for “enforcement actions are not within the scope of FDA’s citizen petition procedures,” CDER says, rejecting petition dosing device firm Parenteral Technologies submitted as it prepares for workshop on Pediatric Research Equity Act requirements for OTC NDA sponsors.

Private Equity Poised To Take Control Of Opella But Sanofi Will Retain Sizable Stake

Private Equity Poised To Take Control Of Opella But Sanofi Will Retain Sizable Stake

 
• By 

Control of Sanofi Consumer Healthcare – recently rebranded as Opella – may soon pass to US private-equity firm CD&R but the French firm looks set to retain a substantial stake in a business which has some big Rx-to-OTC switches in the pipeline.

German OTC Marketing News: Launches From Bayer, Stada, Hermes And Klosterfrau

German OTC Marketing News: Launches From Bayer, Stada, Hermes And Klosterfrau

 
• By 

Bayer adds dry eye treatment to its Bepanthen skin care range; Stada launches special edition Elotrans supplement for Eintracht Frankfurt fans; Hermes offers chewable magnesium supplement; and Klosterfrau introduces Oyono Night extension to help troubled sleepers maintain their immunity.


GSK Tab To Clear Zantac Litigation Ledger Of 93% Of Complaints Pending In State Courts: $2.2Bn

GSK Tab To Clear Zantac Litigation Ledger Of 93% Of Complaints Pending In State Courts: $2.2Bn

 

UK pharma also reaches agreement in principle, subject to DoJ approval, to pay $70m to resolve a whistleblower complaint filed by Valisure, the testing lab which in 2019 raised concerns about a potential link between the use of drugs containing ranitidine, a histamine-2 blocker, and cancer.

FDA Workshop To Consider Pediatric Research Rules Compliance By OTCs Available Through NDAs

FDA Workshop To Consider Pediatric Research Rules Compliance By OTCs Available Through NDAs

 

NDAs for additional OTC products containing acetaminophen and/or NSAIDs and indicated for use by children between 2 and less than 12 years old would trigger compliance by application sponsors with the act passed in 2003 to address lack of pediatric use information in drug labeling.

Germany’s Merz Merges With Windstar To Take On OTC Market

Germany’s Merz Merges With Windstar To Take On OTC Market

 
• By 

A leading provider of over-the-counter health and wellbeing products in the DACH region will be created through the merger of Merz Lifecare and Windstar Medical.

Nozzle At Tip Of Problems For Florida Eye Drop Firm: US FDA Warns Of GMP, Monograph Violations

Nozzle At Tip Of Problems For Florida Eye Drop Firm: US FDA Warns Of GMP, Monograph Violations

 

Regenerative Processing replaces nozzle to prevent backflow for its Regener-Eyes drops but FDA warning states numerous questions about sterility at the firm’s plant and about its procedures and systems for preventing microbial contamination.


‘The Possibilities Are Limitless’ – How Bayer CH Is Using AI To Drive Internal Efficiency

‘The Possibilities Are Limitless’ – How Bayer CH Is Using AI To Drive Internal Efficiency

 
• By 

In addition to its recently established Precision Health division, Bayer Consumer Health is using artificial intelligence to save time on routine tasks and to manage supply and demand, the firm’s head of digital transformation and IT, Cristina Nitulescu, tells HBW Insight.

OcuSoft Retains Retaine Brand Name, Looks Askance At Eyeleve Marketer’s Reference

OcuSoft Retains Retaine Brand Name, Looks Askance At Eyeleve Marketer’s Reference

 

After launching Retaine MGD Advanced, OcuSoft says a release by Bruder Healthcare referenced Retaine MGD trademark and statements from a previous OcuSoft announcement about the original product attributed to an optometrist. B+L, Rohto brand and homeopathic firm Relief Products also make US OTC eye care space moves.

Kenvue Launches ‘Branded Entertainment’ Series For Nicorette In The UK

Kenvue Launches ‘Branded Entertainment’ Series For Nicorette In The UK

 
• By 

To coincide with Stoptober – an annual campaign that encourages smokers in the UK to quit smoking for the month of October – Kenvue has launched a digital “branded entertainment” series for smoking cessation brand Nicorette that follows smokers on their quitting journeys.

UK’s Maxwellia Looking For £2m Investment To Fuel ‘Next Phase Of Rapid Growth’

UK’s Maxwellia Looking For £2m Investment To Fuel ‘Next Phase Of Rapid Growth’

 
• By 

Maxwellia is inviting 100 investors to contribute to the “development of new healthcare solutions that will benefit millions, while also playing a role in shaping the future of self-care.”


Perelel Adds Women’s Health Education Platform, Plum Debuts With Vaginal Area Dryness Serum

Perelel Adds Women’s Health Education Platform, Plum Debuts With Vaginal Area Dryness Serum

 

Perelel acquiring Loom online platform providing reproductive health, sexual wellness and parenting education. First direct-to-consumer product for Curive Healthcare’s Plum brand formulated for vaginal area dryness.

People On The Move: Appointments At Norgine, IPHA, Orifarm

People On The Move: Appointments At Norgine, IPHA, Orifarm

 
• By 

Leadership changes at Norgine, IPHA and Orifarm feature in this week's round-up of European consumer health people news.

Edgewell Stirs Leadership, Brewing Industry Veteran Executive Leads North America Business

Edgewell Stirs Leadership, Brewing Industry Veteran Executive Leads North America Business

 

Jessica Spence joins as North American president while CFO Dan Sullivan becomes COO and Francesca Weissman, finance and business strategy SVP, adds CFO to her title in latest executive office changes by the marketer of brands including Schick men's and women’s shaving, Playtex, Stayfree, Carefree and o.b. feminine care and Banana Boat and Hawaiian Tropic sun care.

Reporting Problems To US FDA Simplified After Delayed Response To Formula Plant Complaint

Reporting Problems To US FDA Simplified After Delayed Response To Formula Plant Complaint

 

Streamlined process for reporting problems is key piece of “unified Human Foods Program” which officially launched on 1 October, as Commissioner Robert Califf says, “a new model for field operations and other modernization efforts.”


US FDA Forecasts Monograph Program Activities As Overhaul Transitions From Construction Phase

US FDA Forecasts Monograph Program Activities As Overhaul Transitions From Construction Phase

 

Nonbinding forecast, fourth for the program, includes risks associated with codeine-containing cough medicine as a topic FDA will include in ongoing evaluation of GRASE for pediatric cough cold drug products marketed under monograph for cold, cough, allergy, bronchodilator and anti-asthmatic OTC drugs.

Haleon Strengthens Control Of China JV, Agrees Option To Buy

Haleon Strengthens Control Of China JV, Agrees Option To Buy

 
• By 

Joint venture business which markets Haleon's OTC drug brands in China will soon be 88% owned by the UK-based firm.

Mucinex Brand Enters Drug-Free Space With Saline Nasal Spray Featuring Dual Nozzles

Mucinex Brand Enters Drug-Free Space With Saline Nasal Spray Featuring Dual Nozzles

 

Mucinex Sinus saline nasal spray is designed to treat sinus-related symptoms as “first-ever drug-free saline product” with a dual nozzle offering two spray settings, marketer Reckitt-Benckiser says.

Supplement Industry Battle Against States Imposing Age-Restricted Sales Swings To NJ

Supplement Industry Battle Against States Imposing Age-Restricted Sales Swings To NJ

 

Council for Responsible Nutrition contends New Jersey bill, which Assembly Health Committee amended with substantial language to make restrictions more stringent on 23 September, is targeted as inaccurately as restrictions in New York effective in April.